HepCAP | NYS Hep C Patient Assistance Program (NYS DOH)
What is HepCAP?

See where HepCAP is offered in New York City.
Services:
-
Initial Hep C Medical and Treatment Evaluation
The purpose of this service is to establish the state of Hep C disease, monitor chronic liver disease, such as cirrhosis and liver cancer, and evaluate for and/or initiate Hep C anti-viral therapy.
Services include: brief interim history; limited physical exam; medication administration (i.e. weekly dispensing of hep C pills); side-effect monitoring; hepatitis A and B vaccination series as indicated; liver screening (i.e. ultrasound, blood test or liver biopsy) and laboratory testing (including Hep C RNA and HIV testing). -
Hep C Treatment Monitoring
This service includes on-going monitoring recommended during Hep C treatment and up to six months after treatment is complete.
Services include: brief interim history; limited physical exam; medication administration (i.e., weekly dispensing of Hep C pills if needed); side-effect monitoring; continuation of hepatitis A and B vaccination series as indicated; laboratory testing (including Hep C RNA) and mental health assessments.
NOTE: HepCAP will not cover the costs of the anti-viral therapy, but will help clients to apply to Patient Assistance Programs, available through the pharmaceutical companies currently developing Hep C anti-viral medications.
Patient eligibility:
- Must be infected only with Hep C, and have a positive viral load. Cannot have HIV.
- Live in New York State (may be homeless or undocumented)
- Earn less than 435% of the Federal Poverty Level (FPL) ($44,000 for a household of one person). FPL varies based on household size and is updated annually. Households cannot have liquid assets greater than $25,000. Liquid assets are cash, savings, stocks, bonds, etc. Liquid assets do not include car, home or federally recognized retirement accounts.
Provider eligibility:
Due to limited funding, only those providers funded by the New York State Department of Health AIDS Institute, to integrate hep C care and treatment into primary care settings, will be allowed to enroll patients into the program.
Last Updated on July 9, 2024 by HepFree NYC